The 8th World Health Assembly, held in Mexico in 1955, marked the beginning of the Global Malaria Eradication Program (GMEP), an initiative aimed at eliminating malaria worldwide. The program primarily relied on DDT, a powerful insecticide used to kill mosquitoes inside homes. This strategy was highly effective in many regions, including Europe, North America, the Caribbean, parts of Asia, and Central South America. A notable success was in Sri Lanka, where malaria cases fell from about 2.8 million in 1946 to just 18 in 1966. However, the GMEP did not extend its efforts to sub-Saharan Africa, a region that now bears 80% of the world's malaria cases and accounts for around 600,000 deaths annually. At the time, logistical challenges and limited resources meant that sub-Saharan Africa received only a few pilot projects under the program. The GMEP was officially discontinued in 1969 after it became clear that complete eradication was not feasible in many areas. Several factors contributed to its failure, including the development of resistance in mosquitoes to DDT, resistance in the malaria parasite to drugs, and a lack of funding. Additionally, concerns over the environmental impact of DDT led to its restriction and eventual phase-out. As a result, the program shifted from eradication to a focus on disease control. Despite these efforts, malaria has remained a persistent problem in Africa, where the disease is still endemic. According to the latest World Health Organization (WHO) global malaria report, there were an estimated 263 million malaria cases and 597,000 deaths worldwide in 2023. The majority of these deaths—about 95%—occurred in the WHO’s African region, with children under five years old making up around 76% of all malaria-related deaths in that region. Four countries—Nigeria, the Democratic Republic of the Congo, Niger, and Tanzania—account for more than half of all global malaria deaths among children under five, with Nigeria alone responsible for nearly 40% of those deaths. Chronic underfunding remains a major obstacle, as malaria control efforts in 2023 received only $4 billion, far below the targeted $8.3 billion. Despite these challenges, malaria control efforts since 2000 have prevented an estimated 2.2 billion cases and 12.7 million deaths. The introduction of the malaria vaccine in several African countries has also begun to make a difference, with nearly two million children in Ghana, Kenya, and Malawi benefiting from it between 2019 and 2023. The question that remains is whether the global community is now prepared to invest in Africa the same level of resources that were dedicated to malaria eradication in Europe in 1955.